Literature DB >> 17434603

A letter to the editor in reply to "susceptibility to guillain-barre syndrome is associated to polymorphisms of CD1 genes" by Caporale et al. in the J of Neuroimmunology (2006), 177:112-118.

Heejung Bang, Madhu Mazumdar, Dmitri Zaykin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17434603      PMCID： PMC2040171          DOI： 10.1016/j.jneuroim.2007.03.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


× No keyword cloud information.
  12 in total

1.  Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits.

Authors:  H W Deng; W M Chen; R R Recker
Journal:  Genetics       Date:  2001-02       Impact factor: 4.562

2.  The replication requirement.

Authors:  V J Vieland
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

3.  Replication validity of genetic association studies.

Authors:  J P Ioannidis; E E Ntzani; T A Trikalinos; D G Contopoulos-Ioannidis
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

4.  Detecting population stratification using a panel of single nucleotide polymorphisms.

Authors:  Wen-Chung Lee
Journal:  Int J Epidemiol       Date:  2003-12       Impact factor: 7.196

5.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

Authors:  Kirk E Lohmueller; Celeste L Pearce; Malcolm Pike; Eric S Lander; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

Review 6.  Betting odds and genetic associations.

Authors:  Duncan C Thomas; David G Clayton
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

Review 7.  One-sided and two-sided tests and p values.

Authors:  G G Koch
Journal:  J Biopharm Stat       Date:  1991       Impact factor: 1.051

Review 8.  The use of one-sided tests in drug trials: an FDA advisory committee member's perspective.

Authors:  L D Fisher
Journal:  J Biopharm Stat       Date:  1991       Impact factor: 1.051

9.  Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.

Authors:  Christina M Caporale; Franco Papola; Maria A Fioroni; Anna Aureli; Armando Giovannini; Francesca Notturno; Domenico Adorno; Vincenzo Caporale; Antonino Uncini
Journal:  J Neuroimmunol       Date:  2006-07-03       Impact factor: 3.478

10.  One and two sided tests of significance.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1994-07-23
View more
  2 in total

1.  Inferring immune-associated signatures based on a co-expression network in Guillain-Barré syndrome.

Authors:  Xiaoming Zhang; Huixue Zhang; Zhaojun Liu; Ruoyu Guan; Jianjian Wang; Xiaotong Kong; Lixia Chen; Chunrui Bo; Jie Li; Ming Bai; Xiaoyu Lu; Jia Shen; Lihua Wang; Mian Guo
Journal:  Cell Prolif       Date:  2019-05-16       Impact factor: 6.831

2.  Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1.

Authors:  Luis Jaramillo-Valverde; Kelly S Levano; Isolina Villanueva; Meylin Hidalgo; Marco Cornejo; Pilar Mazzetti; Mario Cornejo-Olivas; Cesar Sanchez; Julio A Poterico; Julio Valdivia-Silva; Heinner Guio
Journal:  Mol Genet Genomic Med       Date:  2019-08-28       Impact factor: 2.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.